Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01319630 · ClinicalTrials.gov registry record
The Effect of Three Different Fluids(Albumin 5%, Normal Saline, Hydroxyethyl Starch 130 kD) on Microcirculation in Severe Sepsis/Septic Shock Patients
A clinical trial, sponsored by Mercy Research.
- Completed
- Registry status
- 45
- Enrollment target
NCT01319630 is a clinical trial that has completed, run by Mercy Research. The registered enrollment target is 45 participants.
The verdict
NCT01319630 has completed, sponsored by Mercy Research.
- COMPLETED
- Registry status
- 45 participants
- Enrollment target
Study Summary
Major microvascular blood flow alterations have been documented in patients with severe sepsis. It was also demonstrated that the microcirculation improved in survivors of septic shock but failed to do so in patients dying from acute circulatory failure or with multiple organ failure after shock resolution. Early, effective fluid resuscitation is a key component in the management of patients with severe sepsis and septic shock with the goal of improving tissue perfusion. The best fluid in this early resuscitation phase has been and still is under debate. The aim of this study is to evaluate the effect of Three different Fluids(Albumin 5%, Normal Saline, HES 130 kD) on microcirculation in severe sepsis/septic shock patients using Sidestream Dark Field (SDF) Microscopy and Near-Infrared Spectroscopy (NIRS) analysis.
Interventions
- DEVICE Near Infrared Spectroscopy (NIRS)
- DEVICE Sidestream Dark Field (SDF)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2011-04 |
| Est. Completion | 2016-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01319630
The ClinicalTrials.gov registry entry for NCT01319630 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mercy Research, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Near Infrared Spectroscopy (NIRS) is the first listed.
NCT01319630 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01319630 about?
NCT01319630 is a clinical study titled "The Effect of Three Different Fluids(Albumin 5%, Normal Saline, Hydroxyethyl Starch 130 kD) on Microcirculation in Severe Sepsis/Septic Shock Patients". Major microvascular blood flow alterations have been documented in patients with severe sepsis. It was also demonstrated that the microcirculation improved in survivors of septic shock but failed to do so in patients dying from acute circulatory failure or with multiple organ failure after shock res...
What is the current status of trial NCT01319630?
This trial is currently completed. The enrollment target is 45 participants. The study started on 2011-04. Estimated completion is 2016-04.
What interventions are being tested in trial NCT01319630?
The interventions under investigation include: Near Infrared Spectroscopy (NIRS) (DEVICE), Sidestream Dark Field (SDF) (DEVICE).
Who is sponsoring clinical trial NCT01319630?
This trial is sponsored by Mercy Research, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.